Spotlight on L-Theanine

Spotlight on L-Theanine

On our journey to provide anxiety support to pets, TrueCalm™ was carefully formulated to include only the very best ingredients - including L-Theanine. L-Theanine has an amazing history of anti-stress effects and we are proud to include this in our hemp-based TrueCalm™ chews for dogs.

TrueCalm™ is a great way to give your dog support in stressful situations including experiencing loud or busy environments, trips to the vet - and even when dogs are privy to experiencing their owner's stressful times.  Check out a little bit of the science behind it, and consider TrueCalm
™ for your pet!


__________________________________________________________________________

​L-Theanine Reduces Psychological and Physiological Stress Responses.

Kimura K1Ozeki MJuneja LROhira H.

L-Theanine is an amino acid contained in green tea leaves which is known to block the binding of L-glutamic acid to glutamate receptors in the brain. Because the characteristics of L-Theanine suggest that it may influence psychological and physiological states under stress, the present study examined these possible effects in a laboratory setting using a mental task as an acute stressor. 

Twelve participants underwent four separate trials: one in which they took L-Theanine at the start of an experimental procedure, one in which they took L-Theanine midway, and two control trials in which they either took a placebo or nothing. The experimental sessions were performed by double-blind, and the order of them was counterbalanced.

The results showed that L-Theanine intake resulted in a reduction in the heart rate (HR) and salivary immunoglobulin A (s-IgA) responses to an acute stress task relative to the placebo control condition. Moreover, analyses of heart rate variability indicated that the reductions in HR and s-IgA were likely attributable to an attenuation of sympathetic nervous activation.

Thus, it was suggested that the oral intake of L-Theanine could cause anti-stress effects via the inhibition of cortical neuron excitation.

(Source: ​http://www.ncbi.nlm.nih.gov/pubmed/16930802)



Also in Press Releases

True Leaf Announces Initial Closing  of its Regulation A+ Offering
True Leaf Announces Initial Closing of its Regulation A+ Offering

True Leaf Medicine International Ltd. (“True Leaf” or the “Company”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), announces that it has conducted an initial closing of its previously announced Regulation A+ offering for gross proceeds in the amount of C$6.18 million for 8,883,590 shares.

Continue Reading

Media Advisory: True Leaf CEO to attend Lift Cannabis Expo Vancouver 2018
Media Advisory: True Leaf CEO to attend Lift Cannabis Expo Vancouver 2018

Vancouver, BC – True Leaf Medicine International Ltd. (“True Leaf”), the quality of life company for people and their pets, will be at the 2018 Lift Cannabis Expo this weekend, and founder and CEO Darcy Bomford will be available for scheduled and on-the-spot interviews, Friday, January 12, and during the expo on Saturday, January 13, and Sunday, January 14.

Continue Reading

True Leaf Exercises Option to Purchase 40-acre Site in Lumby, B.C. to Build Cannabis Production Facility
True Leaf Exercises Option to Purchase 40-acre Site in Lumby, B.C. to Build Cannabis Production Facility

True Leaf Medicine International Ltd. has exercised its option to purchase 40 acres of land that encompasses its facility in Lumby, B.C. through its wholly owned subsidiary True Leaf Medicine Inc.

Continue Reading